Nukkleus Inc. (NASDAQ:DFNS) Sees Significant Decrease in Short Interest

Nukkleus Inc. (NASDAQ:DFNS) was the target of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 279,125 shares, a drop of 97.9% from the July 15th total of 13,439,238 shares. Currently, 41.4% of the shares of the company are short sold. Based on an average daily volume of 14,067,878 shares, the short-interest ratio is presently 0.0 days.

Wall Street Analyst Weigh In

Several analysts recently issued reports on DFNS shares. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a research note on Monday, June 29th. Wall Street Zen raised Nukkleus to a “sell” rating in a report on Saturday, July 25th. Finally, Weiss Ratings downgraded Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a report on Monday, July 20th. One analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.

Nukkleus Stock Performance

Shares of NASDAQ:DFNS traded down $0.52 on Tuesday, reaching $36.58. 525,508 shares of the company’s stock were exchanged, compared to its average volume of 9,729,318. The company has a fifty day moving average of $26.06 and a 200-day moving average of $105.46. Nukkleus has a twelve month low of $3.70 and a twelve month high of $1,948.75. The company has a market capitalization of $27.80 million, a price-to-earnings ratio of -0.10 and a beta of -5.80. The company has a current ratio of 0.25, a quick ratio of 0.21 and a debt-to-equity ratio of 0.07.

Nukkleus (NASDAQ:DFNS) last announced its earnings results on Wednesday, May 20th. The company reported ($142.50) EPS for the quarter. The firm had revenue of $3.65 million for the quarter. On average, research analysts predict that Nukkleus will post -4.21 EPS for the current fiscal year.

Hedge Funds Weigh In On Nukkleus

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets bought a new stake in shares of Nukkleus during the 2nd quarter valued at $56,000. Price T Rowe Associates Inc. MD bought a new position in shares of Nukkleus in the fourth quarter worth $57,000. GM Advisory Group LLC bought a new position in shares of Nukkleus in the fourth quarter worth $56,000. Millennium Management LLC acquired a new position in Nukkleus in the fourth quarter valued at about $60,000. Finally, Ausdal Financial Partners Inc. acquired a new position in Nukkleus in the third quarter valued at about $105,000. 12.47% of the stock is owned by institutional investors and hedge funds.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.